月度归档： 2026 年 9 月

What if Africa’s biggest agricultural opportunity is not producing more — but becoming more predictable? As …

Indonesia is moving to scale up lobster aquaculture after a farming trial in Batam produced market-sized lobsters that w…

Japan is turning one of its biggest farming regions into a test bed for the next generation of agricultural automation, …

In order to understand and characterize preclinical models of diseases of the central nervous system (CNS), it is critical to be able to conduct continuous neuroimaging of multiple physiological variables—neuronal activity, blood flow, blood volume, oxygenation, and cellular dynamics—within the CNS microenvironment. This continuous multimodality neuroimaging capability is known as neurosurveillance.

Transcenta Therapeutics says it will grant WuXi Biologics and its affiliates a non-exclusive license to certain technologies relating to Transcenta’s intensified continuous bioprocessing (HiCB) platform and ExcelPro cell culture media.

Samsung Biologics reported that it has inked a $262 million manufacturing agreement with an unnamed European pharmaceutical company. The deal includes manufacturing commitments, which will be conducted at Samsung Biologics’ Songdo manufacturing site in South Korea extending through 2033.

The results of a study by scientists at Wellcome Sanger Institute, University of Cambridge, University College London, and collaborators indicate that cancer treatments, including chemotherapy and radiotherapy, give a growth advantage to cells with particular genetic changes in healthy tissue. The team used DNA sequencing to map mutations in normal esophagus tissue from esophageal cancer patients who had received either chemotherapy, chemotherapy and radiotherapy, or no treatment before surgery.

The global plant science community is taking a more coordinated approach to one of the biggest challenges in modern crop…

Potato planting is increasingly becoming a question of how precisely machinery can manage soil conditions, planting dept…